Drug Profile
Research programme: cancer therapeutics - Placon Therapeutics
Alternative Names: BTP-188Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator Placon Therapeutics
- Class Antineoplastics; Drug conjugates; Platinum complexes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for research development in Cancer in USA
- 10 Jan 2017 Early research in Cancer in USA (unspecified route) (Placon Therapeutics pipeline)